Search Results - "송홍석"

Refine Results
  1. 1

    Targeted therapy of ovarian cancer including immune check point inhibitor by Kim, Jin Young, Cho, Chi Heum, Song, Hong Suk

    Published in The Korean journal of internal medicine (01-09-2017)
    “…Epithelial ovarian cancer is the eighth most common cause of cancer-related deaths in women because most patients present with advanced stage disease at the…”
    Get full text
    Journal Article
  2. 2

    Metachronous double primary cancer after treatment of breast cancer by Kim, Jin Young, Song, Hong Suk

    Published in Cancer research and treatment (01-01-2015)
    “…The pattern of double primary cancer after treatment for breast cancer is important for patient survival. We analyzed 108 cases of metachronous double primary…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Phase II Study of Dovitinib in Patients with Castration-Resistant Prostate Cancer (KCSG-GU11-05) by Choi, Yoon Ji, Kim, Hye Sook, Park, Se Hoon, Kim, Bong-Seog, Kim, Kyoung Ha, Lee, Hyo Jin, Song, Hong Suk, Shin, Dong-Yeop, Lee, Ha Young, Kim, Hoon-Gu, Lee, Kyung Hee, Lee, Jae Lyun, Park, Kyong Hwa

    Published in Cancer research and treatment (01-10-2018)
    “…Fibroblast growth factor (FGF) signals are important in carcinogenesis and progression of prostate cancer. Dovitinib is an oral, pan-class inhibitor of…”
    Get full text
    Journal Article
  5. 5

    Concurrent Chemoradiotherapy in Locally Advanced Esophageal Cancer by 변상준, 김진희, 김옥배, 송홍석

    Published in Radiation oncology journal (01-03-2011)
    “…Purpose: This study was designed to evaluate the results of local control, survival rate, prognostic factors, and failure pattern in locally advanced…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Metachronous double primary cancer after diagnosis of gastric cancer by Kim, Jin Young, Jang, Won Young, Heo, Mi Hwa, Lee, Kang Kuk, Do, Young Rok, Park, Keon Uk, Song, Hong Suk, Kim, Yoon Nyun

    Published in Cancer research and treatment (01-09-2012)
    “…The pattern of double primary cancers after treatment for gastric cancer is important for a patient's survival. We analyzed the clinicopathologic data of 214…”
    Get full text
    Journal Article
  8. 8

    Circulating Plasma Biomarkers for TSU-68, an Oral Antiangiogenic Agent, in Patients with Metastatic Breast Cancer by Yoo, Changhoon, Kim, Sung-Bae, Ro, Jungsil, Im, Seock-Ah, Im, Young-Hyuck, Kim, Jee Hyun, Ahn, Jin-Hee, Jung, Kyung Hae, Song, Hong Suk, Kang, Seok Yun, Park, Hee Sook, Chung, Hyun-Cheol

    Published in Cancer research and treatment (01-04-2016)
    “…This study analyzed the role of plasma biomarkers for TSU-68 in a previous phase II trial comparing TSU-68 plus docetaxel and docetaxel alone in patients with…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    담낭에 발생한 전장낭 1예 by 허필석, Pil Seog Heo, 김용범, Yong Bum Kim, 송홍석, Hong Seog Song, 김재삼, Jai Sam Kim, 이진헌, Jin Heon Lee, 김학양, Hak Yang Kim, 유재영, Jae Young Yoo, 김주섭, Joo Seop Kim

    Published in The Korean journal of gastroenterology (01-01-2000)
    “…During the early embryonal stage of foregut development, malformations may be encountered. Foregut duplications are considered to be developed due to abnormal…”
    Get full text
    Journal Article
  16. 16

    잔위암 2예 by 이진헌, Jin Heon Lee, 김성균, Seong Gyun Kim, 김학양, Hak Yang Kim, 서지영, Ji Young Seo, 이자영, Ja Young Lee, 엄광석, Kwang Seok Eom, 신운건, Woon Geon Shin, 송홍석, Hong Seok Song, 남은숙, Eun Sook Nam, 김용범, Yong Bum Kim, 유재영, Jae Young Yoo

    Published in The Korean journal of gastroenterology (01-01-2000)
    “…The prevalence of gastric stump cancer ranges from 0.8% to 8.9% in other countries, but there has been a few reports in Korea. Specific factors responsible for…”
    Get full text
    Journal Article
  17. 17
  18. 18

    위 절제술 후 내시경으로 발견된 역행성 장중첩중 by 이혁, Hyeug Lee, 김은옥, Eun Ok Kim, 신주영, Ju Young Shin, 오승현, Seung Hyun Oh, 송홍석, Hong Seok Song, 전은정, Eun Jung Jeon, 오정환, Jung Hwan Oh, 정정조, Jeong Jo Jeong, 최상욱, Sang Wook Choi, 김성근, Sung Geun Kim, 윤상섭, Sang Seob Yun

    Published in Taehan Sohwagi Naesigyŏng Hakhoe chi (30-08-2008)
    “…역행성 장중첩증은 위장관문합술 후 드물게 나타나는 합병증이다. 특히 위 수술 후 발생하는 역행성 공장-위 중첩증은 0.1% 정도의 빈도를 보이며, 역행성 장중첩의 원인은 잘 알려져 있지 않다. 증상 발현 후 높은 사망률을 보이고 치료하지 않을 시 거의 100%의 사망률을 보이기 때문에…”
    Get full text
    Journal Article
  19. 19
  20. 20